|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.400 EUR | -1.41% |
|
-3.45% | +5.26% |
| 28/04 | Alumexx N.V. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 30/25/30 | Alumexx N.V. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.73 | 6.8 | 5.59 | 4.14 | 5.55 | |||||
Return on Total Capital | 20.26 | 10.61 | 7.12 | 4.86 | 6.47 | |||||
Return On Equity % | 29.2 | 9.5 | -4.53 | 14.05 | -14.07 | |||||
Return on Common Equity | 29.2 | 9.5 | -4.53 | 14.05 | -14.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 25.97 | 28.89 | 44.12 | 52.96 | 51.8 | |||||
SG&A Margin | 3.35 | 5.28 | 10.01 | 24.25 | 26.15 | |||||
EBITDA Margin % | 7.07 | 4.63 | 10.29 | 10.76 | 16.61 | |||||
EBITA Margin % | 7.07 | 4.59 | 8.86 | 9.29 | 10.7 | |||||
EBIT Margin % | 6.23 | 3.81 | 5.77 | 6.6 | 7.97 | |||||
Income From Continuing Operations Margin % | 4.98 | 1.7 | -0.36 | 1.64 | -1.73 | |||||
Net Income Margin % | 4.98 | 1.7 | -0.36 | 1.64 | -1.73 | |||||
Net Avail. For Common Margin % | 4.98 | 1.7 | -0.36 | 1.64 | -1.73 | |||||
Normalized Net Income Margin | 3.78 | 2.3 | 0.76 | 0.88 | -0.88 | |||||
Levered Free Cash Flow Margin | -7.97 | 7.66 | -25.99 | 11.57 | 7.93 | |||||
Unlevered Free Cash Flow Margin | -7.91 | 7.7 | -23.31 | 14.83 | 14.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 3.01 | 2.85 | 1.55 | 1 | 1.11 | |||||
Fixed Assets Turnover | 96.54 | 22.83 | 7.82 | 5.12 | 6.27 | |||||
Receivables Turnover (Average Receivables) | 20.53 | 19.96 | 28.24 | 13.86 | 15.3 | |||||
Inventory Turnover (Average Inventory) | 9.19 | 6.77 | 2.81 | 1.48 | 1.69 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.76 | 1.83 | 1.7 | 1.75 | 2.13 | |||||
Quick Ratio | 0.92 | 1.09 | 0.4 | 0.37 | 0.65 | |||||
Operating Cash Flow to Current Liabilities | -0.42 | 0.42 | 0.1 | 0.57 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 17.78 | 18.29 | 12.93 | 26.4 | 23.85 | |||||
Days Outstanding Inventory (Average Inventory) | 39.71 | 53.92 | 129.95 | 246.56 | 216.05 | |||||
Average Days Payable Outstanding | 52.31 | 37.51 | 18.88 | 63.04 | 66.83 | |||||
Cash Conversion Cycle (Average Days) | 5.18 | 34.7 | 124 | 209.92 | 173.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 7.44 | 41.08 | 736.14 | 538.35 | 514.35 | |||||
Total Debt / Total Capital | 6.93 | 29.12 | 88.04 | 84.33 | 83.72 | |||||
LT Debt/Equity | - | 33.48 | 592.1 | 450.67 | 434.94 | |||||
Long-Term Debt / Total Capital | - | 23.73 | 70.81 | 70.6 | 70.8 | |||||
Total Liabilities / Total Assets | 44.58 | 52.28 | 90.5 | 86.77 | 85.8 | |||||
EBIT / Interest Expense | 59.29 | 61.6 | 1.34 | 1.26 | 0.75 | |||||
EBITDA / Interest Expense | 73.86 | 85.8 | 3.14 | 2.81 | 1.57 | |||||
(EBITDA - Capex) / Interest Expense | 73.86 | 85.8 | 2.63 | 2.56 | 1.51 | |||||
Total Debt / EBITDA | 0.19 | 1.51 | 6.19 | 4.59 | 3.83 | |||||
Net Debt / EBITDA | -0.46 | -0.34 | 5.95 | 4.57 | 3.52 | |||||
Total Debt / (EBITDA - Capex) | 0.19 | 1.51 | 7.39 | 5.04 | 3.97 | |||||
Net Debt / (EBITDA - Capex) | -0.46 | -0.34 | 7.1 | 5.02 | 3.65 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 61.44 | 21.33 | 325.19 | 12.9 | 2.51 | |||||
Gross Profit, 1 Yr. Growth % | 91.58 | 34.97 | 549.38 | 34.79 | 0.26 | |||||
EBITDA, 1 Yr. Growth % | 62.98 | -20.59 | 845.72 | 14.14 | 58.22 | |||||
EBITA, 1 Yr. Growth % | 62.98 | -21.23 | 720.75 | 11.46 | 18.03 | |||||
EBIT, 1 Yr. Growth % | 78.11 | -25.78 | 543.83 | 5.78 | 23.9 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 91.91 | -58.74 | -190.51 | 197.22 | -208.1 | |||||
Net Income, 1 Yr. Growth % | 91.91 | -58.74 | -190.51 | 197.22 | -208.1 | |||||
Normalized Net Income, 1 Yr. Growth % | 95.63 | -26.3 | 40.4 | -26.2 | -202.9 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 87.82 | -60 | -175.01 | 157.8 | - | |||||
Accounts Receivable, 1 Yr. Growth % | 112.02 | -16.33 | 459.62 | -13.84 | 0.65 | |||||
Inventory, 1 Yr. Growth % | 308.53 | -3.02 | 1.44T | -5.28 | -10.26 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -50 | 1.34T | 1.13T | -11.6 | -21.65 | |||||
Total Assets, 1 Yr. Growth % | 13.52 | 40.83 | 1.14T | -9.48 | -5.66 | |||||
Tangible Book Value, 1 Yr. Growth % | 95.23 | 24.56 | -1.23T | -15.28 | -9.31 | |||||
Common Equity, 1 Yr. Growth % | 34.19 | 21.26 | 146.77 | 15.59 | 1.59 | |||||
Cash From Operations, 1 Yr. Growth % | -168.15 | -211.68 | 107.11 | 402.73 | -39.88 | |||||
Capital Expenditures, 1 Yr. Growth % | - | - | - | -32.31 | -52.85 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -193.36 | -216.64 | -1.54T | -146.25 | -29.8 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -191.49 | -218.21 | -1.39T | -166.46 | 0.48 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 69.59 | 39.96 | 127.13 | 120.09 | 7.58 | |||||
Gross Profit, 2 Yr. CAGR % | 90.24 | 60.8 | 196.05 | 197.99 | 16.25 | |||||
EBITDA, 2 Yr. CAGR % | 71.57 | 13.76 | 174.04 | 235.63 | 34.39 | |||||
EBITA, 2 Yr. CAGR % | 71.57 | 13.3 | 154.26 | 213.14 | 14.7 | |||||
EBIT, 2 Yr. CAGR % | 99.76 | 14.97 | 118.59 | 189.54 | 14.48 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 135.23 | -11.01 | -38.89 | 116.47 | 79.25 | |||||
Net Income, 2 Yr. CAGR % | 135.23 | -11.01 | -38.89 | 116.47 | 79.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | 130.27 | 20.07 | 1.72 | 36.33 | -12.86 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 131.27 | -13.33 | -45.23 | 82.58 | - | |||||
Accounts Receivable, 2 Yr. CAGR % | 29.49 | 33.19 | 116.39 | 166.16 | -6.88 | |||||
Inventory, 2 Yr. CAGR % | 714.3 | 99.05 | 285.89 | 279.96 | -7.8 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -42.26 | 168.25 | 1.23T | 229.38 | -16.78 | |||||
Total Assets, 2 Yr. CAGR % | 32.56 | 26.44 | 317.83 | 234.52 | -7.59 | |||||
Tangible Book Value, 2 Yr. CAGR % | 87.63 | 55.94 | 275.67 | 201.1 | -12.34 | |||||
Common Equity, 2 Yr. CAGR % | 37.62 | 27.56 | 72.98 | 76.1 | 8.37 | |||||
Cash From Operations, 2 Yr. CAGR % | 132.76 | -12.76 | 52.09 | 222.68 | 73.85 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | - | - | - | -43.51 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 80.77 | 4.36 | 310.14 | 170.46 | -43.02 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 84.33 | 3.99 | 289.97 | 205.42 | -18.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 61.99 | 51.68 | 102.7 | 80.47 | 70.6 | |||||
Gross Profit, 3 Yr. CAGR % | 73.54 | 69.68 | 156.07 | 128.85 | 107.26 | |||||
EBITDA, 3 Yr. CAGR % | 517.54 | 32.71 | 130.45 | 107.58 | 161.21 | |||||
EBITA, 3 Yr. CAGR % | 517.54 | 32.36 | 119.23 | 97.67 | 126.2 | |||||
EBIT, 3 Yr. CAGR % | 92.7 | 43.61 | 104.17 | 83.92 | 118.18 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 174.79 | 31.68 | -10.51 | 24.58 | 71.74 | |||||
Net Income, 3 Yr. CAGR % | 174.79 | 31.68 | -10.51 | 24.58 | 71.74 | |||||
Normalized Net Income, 3 Yr. CAGR % | 76.74 | 57.51 | 26.5 | 11.06 | 24.13 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 171.74 | 28.85 | -17.4 | 10.07 | - | |||||
Accounts Receivable, 3 Yr. CAGR % | 46.59 | 11.95 | 114.92 | 80.98 | 92.47 | |||||
Inventory, 3 Yr. CAGR % | - | 300.64 | 293.29 | 141.02 | 134.87 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 68.65 | 345.31 | 438.47 | 104.08 | |||||
Total Assets, 3 Yr. CAGR % | 24.71 | 35.26 | 170.62 | 150.72 | 119.37 | |||||
Tangible Book Value, 3 Yr. CAGR % | 87.17 | 63.68 | 202.03 | 124.36 | 101.84 | |||||
Common Equity, 3 Yr. CAGR % | 27.34 | 31.93 | 58.94 | 55.51 | 46.6 | |||||
Cash From Operations, 3 Yr. CAGR % | 16.46 | 82.22 | 16.38 | 126.56 | 84.29 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.33 | 56.21 | 150.43 | 104.34 | 72.53 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20 | 58.95 | 140.51 | 122.58 | 110.84 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | 358.24 | 85.44 | 76.03 | 57.61 | |||||
Gross Profit, 5 Yr. CAGR % | - | 371.69 | 114.88 | 112.55 | 87.25 | |||||
EBITDA, 5 Yr. CAGR % | 49.06 | - | 346.19 | 92.35 | 87.32 | |||||
EBITA, 5 Yr. CAGR % | 41.51 | -2.5 | 333.02 | 86.79 | 71.55 | |||||
EBIT, 5 Yr. CAGR % | 37.97 | -6.06 | 102.67 | 90.1 | 68.86 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 31.32 | -20.67 | 50.61 | 60.65 | 32.03 | |||||
Net Income, 5 Yr. CAGR % | 31.32 | -20.67 | 50.61 | 60.65 | 32.03 | |||||
Normalized Net Income, 5 Yr. CAGR % | 36.51 | -7.39 | 41.7 | 48.67 | 22.49 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 19.81 | -28.01 | 43.19 | 48.13 | - | |||||
Accounts Receivable, 5 Yr. CAGR % | - | 183.92 | 71.3 | 58.3 | 66.12 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | 292.23 | 119.83 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 120.43 | 127.67 | |||||
Total Assets, 5 Yr. CAGR % | 33.47 | 19.58 | 102.28 | 94.3 | 75.98 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.56 | 77.93 | 147.32 | 108.87 | 82.05 | |||||
Common Equity, 5 Yr. CAGR % | 21.26 | 20.77 | 43.94 | 48.09 | 38.67 | |||||
Cash From Operations, 5 Yr. CAGR % | -7.93 | 10.13 | 29.58 | 129.02 | 36.65 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 24.56 | 38.59 | 96.52 | 94.56 | 41.1 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 24.53 | 38.73 | 92.28 | 106.4 | 58.92 |
- Stock Market
- Equities
- ALX Stock
- Financials Alumexx N.V.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















